GARDian3 trial - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record

Representative image of a large-scale copper mining operation in Chile, reflecting investor focus on Antofagasta PLC shares, Q1 2026 production stability, and the Centinela Second Concentrator growth story.

Antofagasta (LSE: ANTO) surges 5% as Q1 output beats consensus and Centinela build holds schedule

Shubman Gill’s 86 steers Gujarat Titans past Kolkata Knight Riders in IPL 2026

Kizik debuts Freedom Run, betting step-in technology can break into performance running

Kizik launches Freedom Run as it pushes hands-free footwear into the performance running market

Read More

Pharma Industry News

How the GARDian3 trial could define the next commercial frontier in ophthalmic gene therapy

Discover how Ocugen, Inc.’s GARDian3 trial could redefine the commercial future of ophthalmic gene therapy and what investors should watch next.

bySoujanya Ravi

April 4, 2026

web analytics